vimarsana.com

Latest Breaking News On - Transepithelial cross linking - Page 1 : vimarsana.com

Glaukos Technologies Featured in Numerous Scientific Abstracts at the 2023 American Society of Cataract and Refractive Surgery Annual Meeting

Glaukos Corporation , an ophthalmic medical technology and pharmaceutical company focused on novel therapies for the treatment of glaucoma, corneal disorders and retinal diseases, announced today. | May 1, 2023

Glaukos Technologies Featured in Numerous Scientific Abstracts at the 2023 American Society of Catar

ALISO VIEJO, Calif. (BUSINESS WIRE) Glaukos Corporation (NYSE: GKOS), an ophthalmic medical technology and pharmaceutical company focused on novel therapies for the treatment of glaucoma, corneal disorders and retinal diseases, announced today that its technologies will be featured in various scientific programmin.

© 2024 Vimarsana

vimarsana © 2020. All Rights Reserved.